MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

LMB News

Human Antibodies developed for Treatment of Lupus and Anthrax

Published on

Two therapies with their roots in antibody technology developed in the LMB and the Scripps Research Institute* have recently emerged as promising new drug candidates to treat lupus, a potentially fatal autoimmune disease, and anthrax, a pressing concern due to bioterrorism. The drug candidates—belimumab (BENLYSTATM, formerly LumphoStat-B®), developed by Human Genome Sciences with GlaxoSmithKine as […]